Latest Headlines

Citigroup: “Time To Buy Agios Pharmaceuticals (NASDAQ:AGIO)”

Margaret Downey

Investors sentiment increased to 1.22 in 2017 Q4. Its up 0.01, from 1.21 in 2017Q3. It is positive, as 19 investors sold Agios Pharmaceuticals, Inc. shares while 48 reduced holdings. 27 funds opened positions while 55 raised stakes. 45.70 million shares or 2.27% more from 44.69 million shares in 2017Q3 were reported. ...